Cite
APA Citation
Heuser, M., Fiedler, W., Block, A., de Leeuw, D. C., van de Loosdrecht, A., Astrid Tschan-Plessl, A., Passweg, J., Kloos, A., Schwarzer, A., Venturini, L., Duru, A. D., Pinkernell, K., & Ganser, A. (n.d.). p1456: EARLY SAFETY AND CLINICAL COURSE OF PATIENTS WITH ACUTE MYELOID LEUKEMIA AND MEASURABLE RESIDUAL DISEASE RECEIVING GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION. HemaSphere, 6, 1338–1339. http://access.bl.uk/ark:/81055/vdc_100159757324.0x000009